Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · IEX Real-Time Price · USD
1.330
+0.110 (9.02%)
Jul 22, 2024, 11:10 AM EDT - Market open
Iterum Therapeutics Employees
Iterum Therapeutics had 14 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
14
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,541,643
Market Cap
21.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Singular Genomics Systems | 255 |
BiomX | 71 |
Jaguar Health | 49 |
Vincerx Pharma | 42 |
American Shared Hospital Services | 31 |
Oncternal Therapeutics | 30 |
NeurAxis | 19 |
Alterity Therapeutics | 11 |
ITRM News
- 3 hours ago - Iterum Therapeutics Commences Rights Offering - GlobeNewsWire
- 4 weeks ago - Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections - GlobeNewsWire
- 7 weeks ago - Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections - GlobeNewsWire
- 2 months ago - Iterum Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire
- 3 months ago - Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem - GlobeNewsWire
- 4 months ago - Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 - GlobeNewsWire